ArticlePharmaceutics2022

In Vivo Toxicity, Redox-Modulating Capacity and Intestinal Permeability of Novel Aroylhydrazone Derivatives as Anti-Tuberculosis Agents.

Violeta Valcheva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.